The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Taro Pharmaceutical Industries

  • TARO
  • NYSE
  • Consumer Products
  • Latest 145.75
  • Currency US$
  • Change 0.45
  • Percent Change 0.31 %
  • Volume 48,604
  • Fri Jul 11, 2014 04:02 PM EDT NYSE data delayed 15 minutes.
  • Open 148.00
  • Previous Close 145.30
  • High 148.00
  • Low 144.925
  • Bidx0 137.83
  • Askx0 160.00
  • 52-week High07/11 148.00
  • 52-week Low07/11 57.921
  • Beta 1.652
  • Market Cap 6,525.23M
  • EPS 0.0000
  • P/E
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $759,300,000
  • Earnings $360,390,000
  • Return on Equity n/a

Cash Flow

  • Cash Flow --
  • Cash $209,960,000
  • Current Ratio 4.15

12 months ended Dec 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $1,284,370,000
  • Liabilities $263,780,000
  • Liabilities-to-Equity Ratio 0.26

Price Ratios

  • Price to Sales 8.59
  • Price to Book 6.39
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings May 27 n/a Aug 6 n/a
Surprises n/a n/a n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Jul 13, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.

Related Securities
Symbol Type Latest % Chg

Officers

  • Kal Sundaram Director and Chief Executive O
  • Dilip Shanghvi Director and Chairman of the B
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

14 HAKTOR ST
HAIFA BAY, L3
10532

Phone: (914)-345-9001
Fax: (914)-3456169

michael.kalb@taro.com
www.taro.com

Ideas & Discussion

Live Discussion of TARO on StockTwits